322 related articles for article (PubMed ID: 3205597)
1. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Downes J; Andrew JH
Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
4. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.
Jacobs MR; Spangler SK; Appelbaum PC
Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):417-21. PubMed ID: 2387295
[TBL] [Abstract][Full Text] [Related]
6. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
de Barbeyrac B; Quentin C; Bebear C
Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
[TBL] [Abstract][Full Text] [Related]
7. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
Betriu C; Sánchez A; Gómez M; Palau ML; Picazo JJ
J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
[TBL] [Abstract][Full Text] [Related]
8. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.
Cuchural GJ; Snydman DR; McDermott L; Iannini PB; Hill GB; Cleary TJ; O'Keefe JP; Pierson CL; Rihs JD; Finegold SM
Clin Ther; 1992; 14(1):122-36. PubMed ID: 1576621
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.
Watanabe K; Ueno K; Kato N; Muto Y; Bandoh K; Tanaka Y; Jotwani R; Goto M; Shimada K; Shimizu K
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1069-73. PubMed ID: 1295761
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
[TBL] [Abstract][Full Text] [Related]
13. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Sanders CV; Aldridge KE
J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
[TBL] [Abstract][Full Text] [Related]
14. The activity of ticarcillin in combination with clavulanic acid against Bacteroides species: an in-vitro comparison with other antibiotics.
de Barbeyrac B; Quentin C; Bébéar C
J Antimicrob Chemother; 1986 May; 17 Suppl C():35-9. PubMed ID: 3636337
[TBL] [Abstract][Full Text] [Related]
15. German multicentre study on the in vitro susceptibility of Bacteroides species. The German Bacteroides Study Group.
Rodloff AC; Werner H; Kresken M; Jansen A
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1074-80. PubMed ID: 1295762
[TBL] [Abstract][Full Text] [Related]
16. Newer beta-lactam agents and the Bacteroides fragilis group.
Cuchural GJ
Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
[TBL] [Abstract][Full Text] [Related]
17. Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents.
Henderson DK; Chow AW; Guze LB
Antimicrob Agents Chemother; 1977 Apr; 11(4):679-82. PubMed ID: 856019
[TBL] [Abstract][Full Text] [Related]
18. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
[TBL] [Abstract][Full Text] [Related]
19. Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
O'Keefe JP; Venezio FR; DiVincenzo CA; Shatzer KL
Antimicrob Agents Chemother; 1987 Dec; 31(12):2002-4. PubMed ID: 3439807
[TBL] [Abstract][Full Text] [Related]
20. Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains.
Jones RN; Pfaller MA; Fuchs PC; Aldridge K; Allen SD; Gerlach EH
Diagn Microbiol Infect Dis; 1989; 12(6):489-94. PubMed ID: 2560421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
